AGTX
Agentix Corp.
Price Chart
Latest Quote
$0.02
+0.00 (+0.00%)
Current Price
| Previous Close | $0.02 |
| Open | $0.04 |
| Day High | $0.04 |
| Day Low | $0.03 |
| Volume | 58,567 |
Stock Information
| Shares Outstanding | 40.07M |
| Total Debt | $353K |
| Cash Equivalents | $6K |
| Net Income | $-590K |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $841K |
| EPS (TTM) | $-0.01 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.19M |
| Income | $-590K |
| Book/sh | $-0.09 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.00 |
Returns & Margins
| ROA | -438.48% |
Ownership
| Insider Ownership | 20.91% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -0.24 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.03 |
| SMA50 | $0.04 |
| SMA200 | $0.04 |
| RSI | 19.19 |
| ATR | 0.0023 |
| Shares Float | 30.64M |
| Volatility | 0.90 |
Performance History
| Week | +0.00% |
| Month | -43.40% |
| Quarter | -56.70% |
| 6 Months | -50.70% |
| YTD | -44.00% |
| Year | -47.50% |
| 3 Years | -70.00% |
| 5 Years | -97.41% |
| 10 Years | -99.88% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $0.02 | 0 |
| 2026-06-02 | $0.02 | 0 |
| 2026-06-01 | $0.02 | 0 |
| 2026-05-29 | $0.02 | 0 |
| 2026-05-28 | $0.02 | 0 |
| 2026-05-27 | $0.02 | 0 |
| 2026-05-26 | $0.02 | 500 |
| 2026-05-22 | $0.02 | 3,000 |
| 2026-05-21 | $0.03 | 0 |
| 2026-05-20 | $0.03 | 68,550 |
| 2026-05-19 | $0.04 | 500 |
| 2026-05-18 | $0.04 | 0 |
| 2026-05-15 | $0.04 | 0 |
| 2026-05-14 | $0.04 | 8,500 |
| 2026-05-13 | $0.04 | 0 |
| 2026-05-12 | $0.04 | 0 |
| 2026-05-11 | $0.04 | 0 |
| 2026-05-08 | $0.04 | 2,633 |
| 2026-05-07 | $0.04 | 0 |
| 2026-05-06 | $0.04 | 0 |
| 2026-05-05 | $0.04 | 2,158 |
| 2026-05-04 | $0.04 | 21,000 |
About Agentix Corp.
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on AGTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2021-08-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $1,240 |
| Operating Revenue | $0 | $0 | $0 | $1,240 |
| Reconciled Cost Of Revenue | - | $0 | $0 | $561 |
| Cost Of Revenue | - | $0 | $0 | $561 |
| Expenses | ||||
| Interest Expense | $42,669 | $21,034 | $1,643 | - |
| Total Expenses | $513,251 | $744,810 | $1,371,756 | $1,341,592 |
| Other Income Expense | $-11,128 | $180,442 | $-406 | - |
| Net Non Operating Interest Income Expense | $-42,669 | $-20,786 | $-1,643 | $5 |
| Interest Expense Non Operating | $42,669 | $21,034 | $1,643 | - |
| Operating Expense | $513,251 | $744,810 | $1,371,756 | $1,341,031 |
| General And Administrative Expense | $332,264 | $569,542 | $660,250 | $975,899 |
| Other Non Operating Income Expenses | - | $198,371 | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Net Interest Income | $-42,669 | $-20,786 | $-1,643 | $5 |
| Interest Income | $0 | $248 | $0 | $5 |
| Normalized Income | $-555,920 | $-567,225 | $-1,373,399 | $-1,340,347 |
| Net Income From Continuing And Discontinued Operation | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Total Operating Income As Reported | $-513,251 | $-744,810 | $-1,371,756 | $-1,340,352 |
| Net Income Common Stockholders | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Net Income | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Net Income Including Noncontrolling Interests | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Net Income Continuous Operations | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Pretax Income | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Interest Income Non Operating | $0 | $248 | $0 | $5 |
| Operating Income | $-513,251 | $-744,810 | $-1,371,756 | $-1,340,352 |
| Gross Profit | - | $0 | $0 | $679 |
| Per Share | ||||
| Diluted EPS | $-0.01 | $-0.01 | $-0.04 | $-0.04 |
| Basic EPS | $-0.01 | $-0.01 | $-0.04 | $-0.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-513,251 | $-546,191 | $-1,371,756 | $-1,340,352 |
| Total Unusual Items | $-11,128 | $-17,929 | $-406 | - |
| Total Unusual Items Excluding Goodwill | $-11,128 | $-17,929 | $-406 | - |
| EBITDA (Bullshit earnings) | $-524,379 | $-564,120 | $-1,372,162 | $-1,340,352 |
| EBIT | $-524,379 | $-564,120 | $-1,372,162 | $-1,340,352 |
| Diluted Average Shares | $40,066,951 | $40,066,951 | $39,232,019 | $34,734,990 |
| Basic Average Shares | $40,066,951 | $40,066,951 | $39,232,019 | $34,734,990 |
| Diluted NI Availto Com Stockholders | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-11,128 | $-17,929 | $-406 | - |
| Research And Development | $180,987 | $175,268 | $711,506 | $365,132 |
| Selling General And Administration | $332,264 | $569,542 | $660,250 | $975,899 |
| Other Gand A | $332,264 | $569,542 | $660,250 | $975,899 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2021-08-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Total Assets | $100,274 | $106,372 | $261,392 | $51,207 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $100,274 | $106,372 | $261,392 | $51,207 |
| Prepaid Assets | $95,797 | $99,837 | - | $0 |
| Cash Cash Equivalents And Short Term Investments | $4,477 | $6,535 | $12,369 | $1,768 |
| Cash And Cash Equivalents | $4,477 | $6,535 | $12,369 | $1,768 |
| Cash Financial | $4,477 | $6,535 | $12,369 | $1,768 |
| Other Current Assets | - | - | $249,023 | - |
| Inventory | - | - | - | $49,439 |
| Debt | ||||
| Net Debt | $238,523 | $136,465 | $37,631 | - |
| Total Debt | $243,000 | $143,000 | $50,000 | - |
| Current Debt And Capital Lease Obligation | $243,000 | $143,000 | $50,000 | - |
| Current Debt | $243,000 | $143,000 | $50,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,204,523 | $2,666,594 | $2,510,555 | $606,942 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $3,204,523 | $2,666,594 | $2,510,555 | $606,942 |
| Current Notes Payable | $243,000 | $143,000 | $50,000 | - |
| Payables And Accrued Expenses | $2,961,523 | $2,523,594 | $2,460,555 | $606,942 |
| Payables | $2,901,326 | $2,499,779 | $2,451,445 | $606,842 |
| Accounts Payable | $2,901,326 | $2,499,779 | $2,451,445 | $606,842 |
| Equity | ||||
| Common Stock Equity | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Total Equity Gross Minority Interest | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Stockholders Equity | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Other Equity Interest | $53,535 | $53,535 | $53,535 | $180,000 |
| Gains Losses Not Affecting Retained Earnings | $35,381 | $12,360 | $765 | - |
| Other Equity Adjustments | $35,381 | $12,360 | $765 | - |
| Retained Earnings | $-6,521,528 | $-5,954,480 | $-5,369,326 | $-1,704,258 |
| Other | ||||
| Ordinary Shares Number | $40,066,951 | $40,066,951 | $40,066,951 | $34,874,605 |
| Share Issued | $40,066,951 | $40,066,951 | $40,066,951 | $34,874,605 |
| Tangible Book Value | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Invested Capital | $-2,861,249 | $-2,417,222 | $-2,199,163 | $-555,735 |
| Working Capital | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Total Capitalization | $-3,104,249 | $-2,560,222 | $-2,249,163 | $-555,735 |
| Additional Paid In Capital | $3,288,296 | $3,288,296 | $3,025,796 | $933,648 |
| Capital Stock | $40,067 | $40,067 | $40,067 | $34,875 |
| Common Stock | $40,067 | $40,067 | $40,067 | $34,875 |
| Current Accrued Expenses | $60,197 | $23,815 | $9,110 | $100 |
| Dueto Related Parties Current | - | $1,538,118 | $1,394,230 | $485,603 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2021-08-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-125,078 | $-110,429 | $-88,541 | $-420,982 |
| Operating Activities | ||||
| Operating Cash Flow | $-125,078 | $-110,429 | $-88,541 | $-420,982 |
| Cash Flow From Continuing Operating Activities | $-125,078 | $-110,429 | $-88,541 | $-420,982 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Cash Flow From Continuing Investing Activities | - | - | - | $0 |
| Financing Activities | ||||
| Financing Cash Flow | $100,000 | $93,000 | $100,000 | $180,000 |
| Cash Flow From Continuing Financing Activities | $100,000 | $93,000 | $100,000 | $180,000 |
| Issuance Of Capital Stock | - | $0 | $50,000 | $180,000 |
| Net Common Stock Issuance | - | $0 | $50,000 | $180,000 |
| Common Stock Issuance | - | $0 | $50,000 | $180,000 |
| Other | ||||
| Repayment Of Debt | $0 | $-70,000 | $0 | - |
| Issuance Of Debt | $100,000 | $163,000 | $50,000 | - |
| Interest Paid Supplemental Data | $0 | $3,223 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $4,477 | $6,535 | $12,369 | $1,768 |
| Beginning Cash Position | $6,535 | $12,369 | $145 | $242,750 |
| Effect Of Exchange Rate Changes | $23,020 | $11,595 | $765 | - |
| Changes In Cash | $-25,078 | $-17,429 | $11,459 | $-240,982 |
| Net Issuance Payments Of Debt | $100,000 | $93,000 | $50,000 | - |
| Net Long Term Debt Issuance | $100,000 | $93,000 | $50,000 | - |
| Long Term Debt Payments | $0 | $-70,000 | $0 | - |
| Long Term Debt Issuance | $100,000 | $163,000 | $50,000 | - |
| Change In Working Capital | $441,970 | $180,649 | $1,146,435 | $538,215 |
| Change In Payables And Accrued Expense | $437,929 | $63,040 | $1,367,578 | $537,654 |
| Change In Prepaid Assets | $4,041 | $117,609 | $-221,143 | $50,000 |
| Net Income From Continuing Operations | $-567,048 | $-585,154 | $-1,373,805 | $-1,340,347 |
| Other Non Cash Items | - | $294,076 | $138,829 | $381,150 |
| Amortization Of Securities | - | - | $19,954 | - |
| Net Business Purchase And Sale | - | - | - | $0 |
| Sale Of Business | - | - | - | $0 |
| Change In Inventory | - | - | - | $-49,439 |
| Provisionand Write Offof Assets | - | - | - | $0 |
| Asset Impairment Charge | - | - | - | $0 |
Fetched: 2026-02-02